Pablo Mora, MD, is the lead author of two new articles published in The Lancet. The articles report Phase 2 results for zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist being studied in adults with type 2 diabetes. Across cohorts, both once-weekly subcutaneous and once-daily oral formulations produced substantial improvements in glycemic control and … Read more
Last summer, Tekton Research announced a strategic partnership with Summit Clinical Research to expand into MASH/NASH clinical trials—one of the most complex and high-demand areas in cardiometabolic research. Less than a year later, that partnership is already delivering measurable results. Early Momentum at Tekton’s Yukon, OK Site The collaboration launched at Tekton’s Yukon, Oklahoma research … Read more
As First Hub Opens, Tekton Adds New Principal Investigator, Dr. Arti Thangudu, and Expands Patient Access to Clinical Research AUSTIN, TX – April 8, 2026 — Tekton Research, a leading multi-site clinical trial organization with 25 research sites across North America, today announced the opening of its San Antonio research hub. A physician-led clinical research … Read more
Today is World Obesity Day – a moment to pause and reflect on one of the fastest-growing global health challenges of our time. More than 1 billion people worldwide are currently living with obesity. By 2035, that number is expected to rise significantly, with nearly half of the global population projected to be living with … Read more
Double Board-Certified Obesity, Diabetes & Integrative Medicine Specialist to Lead Medical Strategy, Sponsor Engagement, and Industry Collaboration AUSTIN, TX – GLOBE NEWSWIRE – Tekton Research, a leading multi-site clinical trial organization with 25 research sites across North America, today announced the appointment of Jara McDonald, MD, FAAFP, DABOM, as Executive Medical Director. Double board-certified in … Read more
Obesity is more than a number on a scale–it’s a chronic disease that significantly increases the risk of developing long-term health conditions. At Tekton Research, we’re committed to advancing research in obesity because we know it’s at the core of a larger health crisis. Understanding and treating obesity isn’t just about weight loss, it’s about … Read more
From continuous glucose monitors to heart rate sensors, the tools patients use to monitor their health have never been more advanced—or more essential. At Tekton, we’re proud to conduct clinical trials for diagnostic devices and health technology that help shape the future of care. Whether it’s validating a new temperature thermometer, testing a next-generation continuous … Read more
Initial Collaboration Launches at Yukon, OK Site Austin, TX – July 1, 2025 – Tekton Research is proud to announce a new strategic partnership with Summit Clinical Research, a leading Integrated Research Organization focused on solving the challenges of MASH/NASH clinical trials. The collaboration marks Tekton’s entry into MASH (Metabolic dysfunction-associated steatohepatitis) research, further expanding … Read more
Tekton Research is thrilled to announce a strategic collaboration with three eminent specialists: Dr. Samata Basani, Dr. Muhammad Siddiqui, and Dr. Heidi Chamberlain Shea. With over 35 years of combined research experience, this partnership represents a significant milestone in Tekton’s mission to drive innovation in endocrinology across the Dallas-Fort Worth (DFW) area and beyond. Dr. … Read more
San Antonio, TX – Tekton Research proudly announces an innovative collaboration with esteemed endocrinology specialist Dr. Shahid Aziz marking the expansion of clinical research in San Antonio. With over two decades of experience in the endocrinology field, Dr. Shahid Aziz, is a double board-certified physician in endocrinology, diabetes, and metabolism as well as internal medicine. … Read more